Yu Tang
- Cancer Research top 10%
- Breast Cancer Treatment Studies 26
- Cancer Genomics and Diagnostics 11
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers 11
- Colorectal Cancer Surgical Treatments 7
- Hepatology top 10%
-
- Monoclonal and Polyclonal Antibodies Research 7
-
- Breast Lesions and Carcinomas 18
-
- Breast Implant and Reconstruction 11
-
- Gastric Cancer Management and Outcomes 8
- Co-authors
- Yanguang CaoMengying HuRihe LiuYing WangYe‐Xiong LiShulian WangSai AnLigeng Xu
- Cited by
- Cancer ResearchOncologyImmunology
- Journals
- Advanced Materials (1 paper)Nature Communications (1 paper)Journal of Clinical Oncology (6 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Yu Tang
104 papers receiving 975 citations
Peers
Comparison fields: 5 of 96
- Cancer Research 234
- Oncology 348
- Immunology 202
- Hepatology 64
- Radiology, Nuclear Medicine and Imaging 145
Countries citing papers authored by Yu Tang
This map shows the geographic impact of Yu Tang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Tang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Tang more than expected).
Fields of papers citing papers by Yu Tang
This network shows the impact of papers produced by Yu Tang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Tang. The network helps show where Yu Tang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yu Tang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 8 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 2 | |
| 7 | 2024 | 1 | |
| 8 | 2023 | 1 | |
| 9 | 2023 | 4 | |
| 10 | 2023 | 19 | |
| 11 | 2023 | 7 | |
| 12 | 2021 | 40 | |
| 13 | 2021 | 10 | |
| 14 | 2020 | 11 | |
| 15 | 2020 | 12 | |
| 16 | 2019 | 1 | |
| 17 | 2018 | 4 | |
| 18 | 2018 | 0 | |
| 19 | 2017 | 1 | |
| 20 | 2007 | 5 |
About Yu Tang
Yu Tang is a scholar working on Cancer Research, Oncology and Pathology and Forensic Medicine, having authored 113 papers that have together received 988 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (26 papers), Breast Lesions and Carcinomas (18 papers), Cancer Genomics and Diagnostics (11 papers), Cancer Immunotherapy and Biomarkers (11 papers), Breast Implant and Reconstruction (11 papers), Gastric Cancer Management and Outcomes (8 papers), Colorectal Cancer Surgical Treatments (7 papers) and Monoclonal and Polyclonal Antibodies Research (7 papers). The work is most often cited by research in Cancer Research (234 citations), Oncology (348 citations) and Immunology (202 citations). Yu Tang has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Yanguang Cao, Mengying Hu, Rihe Liu, Ying Wang, Ye‐Xiong Li, Shulian Wang, Sai An, Ligeng Xu, Hui Fang and Leaf Huang. Their work appears in journals such as Advanced Materials, Nature Communications and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.